Abstract
Background Cardiovascular diseases remain the leading cause of death in the world and approximately 80% of all cardiovascular-related deaths occur in low and middle income countries including Ethiopia.
Methods The aim of the study was to assess the magnitude and spectrum of cardiovascular admissions and its outcomes among medical patients admitted to both Medical Ward and ICU of St. Paul Teaching Hospital from 1st of Jan 2020 to 1st of Jan 2021.
Results Out of 1,165 annual medical admissions, the prevalence of cardiovascular diseases(CVD) was 30.3%. About 60%(212) of patients had advanced congestive heart failure of diverse causes. Hypertensive heart disease (HHD) was the next predominant diagnosis (41%), and also the leading cause of cardiac diseases followed by rheumatic valvular heart disease(RVHD) (18%) and Ischemic heart disease (IHD) (12.2%), respectively. Yong age, rural residence and female sex were associated with RVHD(p=0.001). Stroke also accounted for 20% of CVD admission (hemorrhagic stroke-17% Vs Ischemic stroke-83%). Hypertension was the predominate risk factor for CVD and present in 46.7%(168) of patients. The mean hospital stay was 12days and in hospital mortality rate was 24.3%, septic shock being the commonest immediate cause of death followed by fatal arrhythmia, brain herniation, and massive PTE.
Conclusion Cardiovascular diseases were highly prevalent in the study area causing significant morbidity and mortality. Therefore, Comprehensive approach is needed to timely screen for risk reduction, delay or prevent diseases development and subsequent complications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our study is approved by the IRB committee of St Paul Hospital Millennium Medical College
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
